Every year, lightning incidents claim lives in Rwanda, particularly in the Western and Northern Provinces during rainy seasons. These areas face recurrent tragedies, with certain districts bearing the ...

EB-203 is under clinical development by Eye Bio Korea and currently in Phase II for Wet (Neovascular / Exudative) Macular Degeneration. According to GlobalData, Phase II drugs for Wet (Neovascular / ...